Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-control study

Area of Science:

• Immunogenetics
• Dermatology
• Human Leukocyte Antigen (HLA) research

Background:

• Atopic dermatitis (AD) is a prevalent immune-mediated skin condition.
• Previous research on the association between Human Leukocyte Antigen (HLA) allelic variations and AD has yielded inconsistent results.
• Understanding the genetic underpinnings of AD, particularly HLA associations, is crucial for disease management.

Purpose of the Study:

• To investigate the association between Human Leukocyte Antigen (HLA) Class I genetic variations, specifically peptide binding groove polymorphisms, and atopic dermatitis (AD).
• To identify specific HLA alleles and amino acid residues that confer susceptibility or protection against AD.

Main Methods:

• A case-control study was conducted involving 464 individuals with AD and 388 controls.
• Next-generation sequencing was employed to analyze HLA Class I allelic variation and binding pocket polymorphisms.
• Logistic regression analysis was used to assess the associations between HLA variations and AD, calculating odds ratios with 95% confidence intervals.

Main Results:

• Significant associations were found between specific HLA Class I alleles and AD. B*53:01 was associated with susceptibility, while A*01:01, A*02:01, B*07:02, and C*07:02 were associated with protection.
• Six specific amino acid residues within the HLA Class I binding pockets were identified as conferring protection against AD: A9F, A97I, A152V, A156R, B163E, and C116S.
• These findings highlight the role of specific HLA Class I components and individual amino acid residues in modulating AD risk.

Conclusions:

• Specific Human Leukocyte Antigen (HLA) Class I alleles and amino acid residues are significantly associated with susceptibility and protection from atopic dermatitis (AD).
• The identified protective amino acid residues provide a foundation for further research into HLA Class I molecules, peptides, and T-cell responses in AD.
• This study contributes to a deeper understanding of the immunogenetic basis of AD, potentially informing future therapeutic strategies targeting HLA-peptide interactions.